ALDH1A1 and lung cancer: Using an isogenic panel of cisplatin-resistant NSCLC cell lines, the in vitro re-sensitising capacity of retinoic acid exploitation was assessed across multiple functional parameters, including its effect on the presence of the ALDH1+ve CSC population in cisplatin-resistant lung cancer.